Download Citation
Article Source:
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated era
Sridhara S,
Gungor AB,
Erol HK,
Al-Obaidi M,
Zangeneh TT,
et al.
(2023)
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated era.
PLOS ONE 18(4): e0279326.
https://doi.org/10.1371/journal.pone.0279326